Amylyx Pharmaceuticals
AMLX
AMLX
120 hedge funds and large institutions have $188M invested in Amylyx Pharmaceuticals in 2024 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 35 increasing their positions, 39 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
10% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 39
30% less call options, than puts
Call options by funds: $1.36M | Put options by funds: $1.94M
Holders
120
Holding in Top 10
–
Calls
$1.36M
Puts
$1.94M
Top Buyers
| 1 | +$17.6M | |
| 2 | +$5.72M | |
| 3 | +$3.36M | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$2.26M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$1.93M |
Top Sellers
| 1 | -$4.54M | |
| 2 | -$4.37M | |
| 3 | -$3.73M | |
| 4 |
AWG
Alpha Wave Global
New York
|
-$1.97M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$1.74M |